Their downregulation promotes oxidative stress and mitochondrial dysfunction, which, together with activation of kinases such as GSK-3β and CDK5, contributes to tau hyperphosphorylation—an early neuropathological feature of Alzheimer’s disease [82,154]. Here, MAPT is linked to Alzheimer disease.